Cargando…
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a short survival time arising from the mesothelial cells of the pleura. Soluble mesothelin-related peptide (SMRP), osteopontin or EFEMP1 (Fibulin-3) are well described biomarkers for malignant mesothelioma with moderate sensiti...
Autores principales: | Schneider, Marc A., Muley, Thomas, Kahn, Nicolas C., Warth, Arne, Thomas, Michael, Herth, Felix J.F., Dienemann, Hendrik, Meister, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342078/ https://www.ncbi.nlm.nih.gov/pubmed/27713145 http://dx.doi.org/10.18632/oncotarget.12474 |
Ejemplares similares
-
Pathways regulating the expression of the immunomodulatory protein glycodelin in non-small cell lung cancer
por: Weber, Rebecca, et al.
Publicado: (2018) -
Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC
por: Schneider, Marc A., et al.
Publicado: (2018) -
AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients
por: Schneider, Marc A., et al.
Publicado: (2017) -
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019) -
Glycodelin – Newer perceptions
por: Gude, Dilip
Publicado: (2011)